Is Abbott Stock Worth Buying at a Discounted P/S Valuation?

Like all its peers, Abbott Laboratories (ABT) faced the industrywide challenges of margin pressure through 2024, stemming from growing inflation, labor shortages and supply chain disruptions, which increased operational costs. However, the company’s ability to pivot and deliver solid results in key areas underscores its resilience and strategic acumen. The company is poised to conclude 2024 on a strong and optimistic trajectory, focusing largely on strategic investments and operational efficiency.Abbott is ...